Marketing & Sales
See launches coming, size markets on real activity, and focus field teams where the clinical activity is.
What this team sees first.
A Pareto chart shows who carries the field. In oncology Phase 3, eight sponsors hold 20.4% of trials; the long tail holds the rest.
Every use case below opens with its signature chart and a recommended set of supporting views, chosen from 91 chart types.
Built for: Competitive Intelligence, Marketing Analytics, Brand, Sales Operations, Key Account Manager.
Eight sponsors hold 20.4% of 186 oncology Phase 3 trials
Comphas oncology Phase 3 board, ClinicalTrials.gov as of 11 Sep 2026. Sponsors anonymised; "Other" groups 121 sponsors.
Ranked by stakes, centrality, reach, frequency and data fit.
Each use case ships with an executive brief, a detailed dossier and a recipe that builds the board in one click.
- MS-11N
#6Approved-product & label landscape
Map what is already approved in an indication, with label scope, alongside the trial pipeline.
For: Competitive Intelligence / Brand Strategy ManagerBullseyeHeatmap / matrixTimeline - MS-01
#9Competitive launch warning system
Use late-stage competitor trial status as an early signal of an imminent product launch.
For: Competitive Intelligence / Brand Strategy ManagerTimelineStrategic group mapBullseye - MS-12N
#28Epidemiology-anchored market sizing
Anchor addressable-population and forecast assumptions in authoritative epidemiology rather than trial enrollment.
For: Marketing Analytics / Forecasting LeadChoropleth mapKPI / metric snapshot panelBar / column chart - MS-02
#41KOL identification
Find the most active trial sites and organizations as a proxy for leading investigators and KOLs.
For: Brand / Marketing ManagerPareto chartForce-directed network graphEgo network - MS-03
#70Market sizing
Estimate the volume of patients currently in trials as a leading indicator of addressable population.
For: Marketing Analytics / Forecasting LeadKPI / metric snapshot panelBar / column chartFan chart - MS-04
#83Whitespace identification
Find disease areas or regions with few active trials, revealing underserved markets.
For: Brand / Commercial Strategy ManagerQuadrant mapBullseyePareto chart - MS-05
#87Territory prioritization
Identify cities and regions with the highest concentration of active trials to focus field reps.
For: Sales Operations / Field Force ManagerPareto chartStacked bar chartTimeline - MS-06
#94Expanded access opportunity tracking
Identify products nearing commercial availability via expanded-access status.
For: Competitive Intelligence / Brand ManagerTimelinePareto chartBar / column chart - MS-07
#95Account planning
Enrich CRM account records with clinical activity data for smarter call planning.
For: Key Account ManagerBullseyePareto chartTimeline - MS-08
#96Congress & event strategy
Identify which indications attract the most investment to size congress presence and budget.
For: Marketing / Congress Planning ManagerTimelineCalendar heatmapPareto chart - MS-09
#98Segment-specific messaging
Tell whether a market is in an experimental or real-world-evidence phase to tailor messaging.
For: Marketing / Brand Communications ManagerBar / column chartPareto chartHeatmap / matrix - MS-10
#99Sales training content
Create objection-handling materials from competitive trial data for the field force.
For: Sales Enablement / Training ManagerBullseyeBar / column chartKPI / metric snapshot panel
Ask the registry a marketing & sales question.
AI reads your question into filters; every number comes straight from the ClinicalTrials.gov API. Don't enter personal or confidential information.
Bring one marketing & sales question to a pilot.
Eight weeks, one programme, success criteria agreed up front.